\r\n <\/p>\n<\/div><\/section> Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Morocco based on the IONA\u00ae test at the Centre de Biologie Riad (Laboriad). By offering this service locally, Laboriad can broaden its offering and provide pregnant women fast, reliable results that reduce the need for invasive tests and the associated stress and anxiety for expectant parents.<\/p>\n Yourgene\u2019s IONA test, offered under the name COSY\u00ae test by Laboriad, is an advanced prenatal screening test to estimate the risk that a fetus may be affected with trisomy 21 (Down\u2019s syndrome), trisomy 18 (Edwards\u2019 syndrome) or trisomy 13 (Patau\u2019s syndrome). The test can also be used to determine the sex of the fetus. It is a complete CE-IVD product for laboratories wishing to offer their own in-house NIPT service. The analysis is performed on a maternal blood sample, using next-generation sequencing technology, with test results available in three days. It has been validated on a highly flexible and scalable workflow, suitable for low- to high-volume sample throughput, enabling clinical laboratories to meet and grow with their rising demands.<\/p>\n Blood samples taken in Morocco are typically sent to countries such as France and Germany for NIPT. Laboriad\u2019s addition of the IONA test to its laboratory workflow allows the company to become a local supplier of NIPT in Morocco, and surrounding regions, broadening access to non-invasive testing in these areas. Laboriad is able to deliver results quickly and reduce the number of failures due to low fetal fraction, which might otherwise occur following shipping delays.<\/p>\n Lyn Rees, Executive Director, Yourgene Health, said: \u201cYourgene is committed to delivering best-in-class NIPT solutions and continues to be a leading player in the global NIPT market and a trusted provider. We are very proud, once again, to be contributing to patient care where it is needed and to be the first to bring NIPT to Morocco through our partnership with pioneering companies, like Laboriad, who are at the forefront of clinical testing in the region.\u201d<\/p>\n \u201cThe establishment of the first NIPT platform in Morocco in collaboration with Yourgene Health, will improve the care of pregnant women in Morocco by giving gynaecologists and pregnant women rapid access to new generation NIPT,\u201d said Dr Jalil Elattar, Director, Centre de Biologie Riad (Laboriad). \u201cThe clinical management of pregnant women in Africa is difficult, as many do not have access to NIPT, due to the complexity of having to send the samples abroad, resulting in costs and additional delays.<\/p>\n We are very pleased to collaborate with Yourgene Health who have installed their NIPT technology in our laboratory, allowing us to finally perform NIPT locally, in less than a week, and make them affordable and more accessible to pregnant women in Morocco,\u201d he added.<\/p>\n Attend Yourgene\u2019s presentation: \u201cNon-invasive prenatal screening using shallow sequencing, a high-performance, evolving technique\u201d at noon on 11 November at the 22E Congr\u00e8s de la Soci\u00e9t\u00e9 Marocaine d’Endoscopie Gyn\u00e9cologique (Hotel Dawliz Art & Spa, Rabat, 10\u201311 November 2023) to learn more.<\/p>\n Visit https:\/\/yourgenehealth.com\/our-products\/nipt-solutions\/nipt\/the-iona-test\/<\/a> for information about Yourgene\u2019s IONA test and https:\/\/www.laboriad.ma\/<\/a> for details of Laboriad\u2019s NIPT service.<\/p>\n<\/div><\/section> <\/p>\n<\/div><\/section><\/div><\/div><\/div><\/main><\/div><\/div> \r\n <\/p>\n<\/div><\/section> The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.<\/strong><\/p>\n <\/p>\n The CE-marked assay provides fast and simple real-time PCR-based detection of SARS-CoV-2 in RNA isolated from the patient samples. Reverse transcription and real-time PCR are performed in one step, so that only one reaction is required per sample.<\/p>\n The test provides high sensitivity due to simultaneous detection of two defined target sequences in the ORF1ab and N genes of the viral genome. The variants alpha (B.1.1.7 lineage), beta (b.1.351 lineage), gamma (P.1 lineage) and delta (B1.617.2 lineage) can be reliably detected.<\/p>\n The test contains an internal amplification control, which serves as an inhibition and extraction control. A SARS-CoV-2 positive control provided in the test kit is analysed as an external control in every test run ensuring dependable results. The complementary EURORealTime Analysis software provides fully automated and standardised evaluation and documentation of results, including all control results. Comprehensive automation options for sample preparation, PCR setup and PCR performance are available.<\/p>\n<\/div><\/section> <\/p>\n<\/div><\/section><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":" The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.<\/p>\n","protected":false},"author":3,"featured_media":20788,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20786"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=20786"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20786\/revisions"}],"predecessor-version":[{"id":20791,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20786\/revisions\/20791"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/20788"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=20786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=20786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=20786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/a>\r\n<\/p>\n<\/div><\/section><\/div>
\nYourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\n<\/div><\/div><\/div>
\n
\nShare this<\/h5>
<\/a>\r\n<\/p>\n<\/div><\/section><\/div>
\nYourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\n<\/div><\/div><\/div>
\n
\nShare this<\/h5>